Profile: ARIUS Research Inc. is a biotechnology company developing antibody therapeutics to treat cancer and other diseases. Our 2007 lead antibody program targets CD44, a target on the surface of cancer cells that is aberrantly expressed in a variety of tumors.
1 Products/Services (Click for related suppliers)
| |||||
• | Monoclonal antibody-based Therapeutics |